Lamivudine therapy for chemotherapy-induced reactivation of hepatitis B virus infection

American Journal of Gastroenterology

Volumn 94, Issue 1, 1999, Pages 249-251

  Ahmed, Aijaz ^a   Keeffe, Emmet B ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOTRANSFERASE; HEPATITIS B(E) ANTIGEN; LAMIVUDINE;

ADULT; AMINOTRANSFERASE BLOOD LEVEL; ARTICLE; CANCER CHEMOTHERAPY; CASE REPORT; HEPATITIS B; HEPATITIS B VIRUS; HUMAN; LYMPHOMA; MALE; PRIORITY JOURNAL; VIRUS REACTIVATION;

ACUTE DISEASE; ANTINEOPLASTIC AGENTS; HEPATITIS B; HEPATITIS B VIRUS; HUMANS; LAMIVUDINE; LYMPHOMA, FOLLICULAR; MALE; MIDDLE AGED; REVERSE TRANSCRIPTASE INHIBITORS; VIRUS ACTIVATION;

EID: 0032953861     PISSN: 00029270     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1572-0241.1999.00808.x     Document Type: Article

References (40)

1. Tanikawa K., Hayashi N., Ichida F., et al. A placebo-controlled phase III study of lamivudine in Japanese patients with chronic hepatitis B infection. Hepatology. 26:1997;259A. (abstract).
2. Ter Borg F., Smorenburg S., De Man R.A., et al. Successful treatment with lamivudine for fulminant hepatic failure caused by chemotherapy-induced hepatitis B virus reactivation. Gastroenterology. 112:1997;A1399. (abstract).
3. Benhamou Y., Dohin E., Lunel-Fabiani F., et al. Efficacy of lamivudine on replication of hepatitis B virus in HIV-infected patients. Lancet. 345:1995;396-397.
4. Dienstag J.L., Perrillo R.P., Schiff E.R., et al. A preliminary trial of lamivudine for chronic hepatitis B infection. N Eng J Med. 333:1995;1657-1661.
5. Gutfreund K.S., Fischer K.P., Tipples G., et al. Lamivudine results in a complete and sustained suppression of hepatitis B virus replication in patients requiring orthotopic liver transplantation for cirrhosis secondary to hepatitis B. Hepatology. 22:1995;328A. (abstract).
6. Perrillo R., Rakela J., Martin P., et al. Lamivudine for Hepatitis B after liver transplantation (OLT). Hepatology. 24:1996;182A. (abstract).
7. Galbraith R.M., Eddleston A.L.W.F., Williams R., et al. Fulminant hepatic failure in leukaemia and choriocarcinoma related to withdrawal of cytotoxic drug therapy. Lancet. 2:1975;528-530.
8. Wands J.R. Subacute and chronic active hepatitis after withdrawal of chemotherapy. Lancet. 2:1975;979. (abstract).
9. Wands J.R., Chura C.M., Roll F.J., et al. Serial studies of hepatitis-associated antigen and antibody in patients receiving antitumor chemotherapy for myeloproliferative and lymphoproliferative disorders. Gastroenterology. 68:1975;105-112.
10. Nagington J., Cossart Y.E., Chen B.J. Reactivation of hepatitis B after transplantation operations. Lancet. 1:1977;558-560.
11. Villa E., Theodossi A., Portmann B., et al. Reactivation of hepatitis B virus infection in two patients Immunofluorescence studies of liver tissue . Gastroenterology. 80:1981;1048-1050.
12. Hoofnagle J.H., Dusheiko G.M., Schafer D.F., et al. Reactivation of chronic hepatitis B virus infection by cancer chemotherapy. Ann Intern Med. 96:1982;447-449.
13. Locasciulli A., Santamaria M., Masera G., et al. Hepatitis B virus markers in children with acute leukemia The effect of chemotherapy . J Med Virol. 15:1985;29-33.
14. Thung S.N., Gerber M.A., Klion F., et al. Massive hepatic necrosis after chemotherapy withdrawal in a hepatitis B virus carrier. Arch Intern Med. 145:1985;1313-1314.
15. Onwubalili J.K. Fulminant hepatic failure in nephrotic syndrome related to withdrawal of immunosuppressive therapy. Postgrad Med J. 64:1988;325-327.
16. Pariente E.A., Goudeau A., Dubois F., et al. Fulminant hepatitis due to reactivation of chronic hepatitis B virus infection after allogenic bone marrow transplantation. Dig Dis Sci. 33:1988;1185-1191.
17. Hanson C.A., Sutherland D.E., Snover D.C. Fulminant hepatic failure in an HBsAg carrier renal transplant patient following cessation of immunosuppressive therapy. Transplantation. 39:1985;311-312.
18. Webster A., Brenner M.K., Prentice H.G., et al. Fatal hepatitis B reactivation after autologous bone marrow transplantation. Bone Marrow Transp. 4:1989;207-208.
19. Grumayer E.R., Panzer S., Ferenci P., et al. Recurrence of hepatitis B in children with serologic evidence of past hepatitis B virus infection undergoing antileukemia chemotherapy. J Hepatol. 8:1989;232-235.
20. Lau J.Y.N., Lai Cl, Lin H.J., et al. Fatal reactivation of chronic hepatitis B virus infection following withdrawal of chemotherapy in lymphoma patients. Q J Med. 73:1989;911-917.
21. Bird GLA, Smith H, Portmann B, et al. Acute liver decompensation on withdrawal of cytotoxic chemotherapy and immunosuppressive therapy in hepatitis B carriers. Q J Med 1989;73:895-2.
22. Flowers M.A., Heathcote J., Wanless I.R., et al. Fulminant hepatitis as a consequence of reactivation of hepatitis B virus infection after discontinuation of low dose methotrexate therapy. Ann Intern Med. 112:1990;381-382.
23. Hanta T., Okita K., Matsuda S., et al. A case of fulminant hepatitis developing in a HBsAg carrier after chemotherapy of malignant lymphoma. Nippon Shokakibyo Gakkai Zasshi. 81:1984;1089-1093.
24. Pinto P.C., Eddie H.U., Bernstein-Singer M., et al. Acute hepatic injury after the withdrawal of immunosuppressive chemotherapy in patients with hepatitis B. Cancer. 65:1990;878-884.
25. Liang R.H.S., Lok A.S.F., Lai C.L., et al. Hepatitis B infection in patients with lymphoma. Hematol Oncol. 8:1990;261-270.
26. Ohtsu T., Sai T., Oka M., et al. Activation of hepatitis B virus infection by chemotherapy containing glucocorticoid in hepatitis B carriers with hematologic malignancies. Jpn J Clin Oncol. 21:1991;360-365.
27. Yoshiba M., Sekiyama K., Sugata F., et al. Reactivation of precore mutant hepatitis B virus leading to fulminant hepatic failure following cytotoxic treatment. Dig Dis Sci. 37:1992;1253-1259.
28. Chemotherapy and hepatitis B. Lancet 1989;2:1136-1137 (editorial).
29. Perrillo R.P., Regenstein F.G., Peters M.G., et al. Prednisone withdrawal followed by recombinant alpha interferon in the treatment of chronic type B hepatitis in a randomized, controlled trial. Ann Intern Med. 109:1988;95-100.
30. Omata M., Imazeki F., Yokosuka O., et al. Recombinant leukocyte A interferon treatment in patients with chronic hepatitis B virus infection. Pharmacokinetics, tolerance and biologic effects. Gastroenterology. 88:1985;870-880.
31. Lok A.S.F., Lai Cl, Lau J.Y.N., et al. Effects of age, serum ALT level and prednisone withdrawal on the response to alpha-interferon (IFN) therapy in Chinese patients with chronic HBV infection. Gastroenterology. 96:1989;A623. (abstract).
32. Lai C.L., Lok A.S.F., Lin H.J., et al. Placebo controlled trial of recombinant alpha-interferon in Chinese HBsAg-carrier children. Lancet. 2:1987;870-880.
33. Lai C.L., Lok A.S.F., Lin H.J., et al. Use of recombinant alpha-2 interferon (r-IFN) with or without steroid in Chinese HBsAg carrier children A prospective double blind controlled trial . Gastroenterology. 96:1989;A618. (abstract).
34. Lok A.S.F., Lai C.L., Wu P.C., et al. Long-term follow-up in a randomized controlled trial of recombinant alpha-2 interferon in Chinese patients with chronic hepatitis B infection. Lancet. 2:1988;298-302.
35. Lok A.S.F., Liang R.H.S., Chiu E.K.W., et al. Reactivation of hepatitis B virus replication in patients receiving cytotoxic therapy. Gastroenterology. 100:1991;182-188.
36. Mitochondrial toxicity - new adverse drug effects. N Eng J Med 1995;333:1146-8 (editorial).
37. Nevens F., Tyrrell D.L., De Man R.A., et al. A six month dose-ranging study of the safety and efficacy of lamivudine in chronic hepatitis B. J Hepatol. 23:(suppl 1):1995;91A. (abstract).
38. Honkoop P., De Man R.A., Zondervan P.E., et al. Histological improvement in patients with chronic hepatitis B virus infection treated with lamivudine is associated with a decrease in HBV-DNA by PCR. Hepatology. 22:1995;328A. (abstract).
39. Lau G.K.K., Liang R., Wu P.C., et al. Use of famciclovir to prevent HBV reactivation in HBsAg-positive recipients after allogeneic bone marrow transplantation. J Hepatol. 28:1998;359-368.
40. Rostaing L., Henry S., Cisterne J.M., et al. Efficacy and safety of lamivudine on replication of recurrent hepatitis B after cadaveric renal transplantation. Transplantation. 64:1997;1624-1627.